Spots Global Cancer Trial Database for pigmented villonodular synovitis
Every month we try and update this database with for pigmented villonodular synovitis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | NCT04938180 | Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor | NCT02471716 | Pigmented Villo... Tenosynovial Gi... | FPA008 | 18 Years - | Five Prime Therapeutics, Inc. | |
| MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) | NCT01643850 | Pigmented Villo... PVNS Giant Cell Tumo... GCCTS Tenosynovial Gi... GCTS | MCS110 Placebo | 12 Years - | Novartis | |
| MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) | NCT01643850 | Pigmented Villo... PVNS Giant Cell Tumo... GCCTS Tenosynovial Gi... GCTS | MCS110 Placebo | 12 Years - | Novartis | |
| Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | NCT01261429 | Pigmented Villo... | Tasigna | 18 Years - | Centre Leon Berard | |
| Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | NCT01261429 | Pigmented Villo... | Tasigna | 18 Years - | Centre Leon Berard | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor | NCT01207492 | Pigmented Villo... Diffuse-type Gi... Tenosynovial Gi... | nilotinib | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | NCT04938180 | Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) | NCT01643850 | Pigmented Villo... PVNS Giant Cell Tumo... GCCTS Tenosynovial Gi... GCTS | MCS110 Placebo | 12 Years - | Novartis | |
| Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor | NCT01207492 | Pigmented Villo... Diffuse-type Gi... Tenosynovial Gi... | nilotinib | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Vimseltinib for Tenosynovial Giant Cell Tumor | NCT05059262 | Tenosynovial Gi... Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi... Tenosynovial Gi... | vimseltinib Placebo | 18 Years - | Deciphera Pharmaceuticals LLC | |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee | NCT04731675 | Tenosynovial Gi... Pigmented Villo... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee | NCT04731675 | Tenosynovial Gi... Pigmented Villo... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease | NCT04952896 | Synovial Diseas... Pigmented Villo... Gout Rheumatoid Arth... | Synovitis diagn... | - | Peking University Third Hospital | |
| Screening of Specific Genes for Pigmented Villous Nodular Synovitis | NCT04955535 | Pigmented Villo... | Arthroscopic sy... | 18 Years - 60 Years | Peking University Third Hospital | |
| Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | NCT01261429 | Pigmented Villo... | Tasigna | 18 Years - | Centre Leon Berard | |
| Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor | NCT02471716 | Pigmented Villo... Tenosynovial Gi... | FPA008 | 18 Years - | Five Prime Therapeutics, Inc. | |
| Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease | NCT04952896 | Synovial Diseas... Pigmented Villo... Gout Rheumatoid Arth... | Synovitis diagn... | - | Peking University Third Hospital | |
| Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) | NCT02371369 | Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi... | Pexidartinib Placebo | 18 Years - | Daiichi Sankyo | |
| Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | NCT05804045 | Tenosynovial Gi... Pigmented Villo... Giant Cell Tumo... | Pimicotinib(ABS... Placebo | 18 Years - | Abbisko Therapeutics Co, Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
